Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000914208-25-000303
Filing Date
2025-08-07
Accepted
2025-08-07 16:27:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5690
  Complete submission text file 0000914208-25-000303.txt   7849
Mailing Address 1331 SPRING STREET NW SUITE 2500 ATLANTA GA 30309
Business Address 1331 SPRING STREET NW SUITE 2500 ATLANTA GA 30309 404-892-0896
Invesco Ltd. (Filed by) CIK: 0000914208 (see all company filings)

EIN.: 980557567 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Subject) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88843 | Film No.: 251194588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)